Skip to content

CRSP NASDAQ

CRISPR Therapeutics

Description

CRSP · NASDAQ

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States.

Wikipedia · CC BY-SA 4.0

Headquarters
US
Reporting currency
USD
Website
Website

Structure of CRISPR Therapeutics

CRISPR Therapeutics

Company

2 connections
UpstreamSupply and dependency
ConstraintsRegulation and exposure
Relationship began2026
CRISPR TherapeuticsCompany · 2 connections
Layer 1

UpstreamSupply and dependency1

ConstraintsRegulation and exposure1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

Showing 1 to 2 of 2

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

CRISPR Therapeutics AG is headquartered in Zug, Switzerland

GlobeNewswire public company news · 2026-10-08 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-08 20:30
    CRISPR Therapeutics AG is headquartered in Zug, Switzerland
    View source
FactEvidence 1

CRISPR Therapeutics has established a proprietary lipid nanoparticle (LNP) delivery platform to enable gene editing in the liver

GlobeNewswire public company news · 2026-10-08 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-08 20:30
    CRISPR Therapeutics has established a proprietary lipid nanoparticle (LNP) delivery platform to enable gene editing in the liver
    View source

Showing 1 to 2 of 2

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Filings

Guidance

Not available: Company signals · Financials